FDA Approves First Gene Therapy for Severe Leukocyte Adhesion Deficiency Type I - fda.gov

FDA Approves First Gene Therapy for Severe Leukocyte Adhesion Deficiency Type I  fda.govFDA approves Rocket gene therapy for rare immune disorder  statnews.comRocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)  Yahoo FinanceFirst therapy funded by California taxpayer dollars is approved to treat rare childhood disorder  GlobeNewswireRocket charts measured trajectory for new gene therapy Kresladi after clearance to launch from FDA  Fierce Pharma